Proflavine作为一种Rev抑制剂,通过靶向结合高亲和力的Rev结合位点,HIV-1的Rev响应要素而发挥作用。
The concentrations of Proflavine (20 mg/kg) in whole blood after intravenous injection decreased rapidly at the beginning and remained stable from around 30 min after dosing.